cbdMD closed at $0.41 on Nov 4, down 3.10%, 82.1% below its 52-week closing high. Volume of 170.4K shares was 1.60× its 20-day average (above normal).
Split-adjusted performance: -0.5% over one month, -55.5% over six months, -51.7% over one year.
In the quarter ended Jun 30, 2026, revenue was $5.55M, up 20.6% from a year earlier, with a net margin of -21.6%.
Short interest was 546.0K shares at the Oct 15 settlement, down 10.6% from the prior report (5.6% of float, 5.4 days to cover).